These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29397453)

  • 1. Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1.
    Hu C; Chen X; Huang Y; Chen Y
    Apoptosis; 2018 Feb; 23(2):132-142. PubMed ID: 29397453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity.
    Hao W; Hu C; Huang Y; Chen Y
    PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy.
    Hao X; Yan Q; Zhao J; Wang W; Huang Y; Chen Y
    PLoS One; 2015; 10(9):e0138911. PubMed ID: 26405806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
    Hu C; Huang Y; Chen Y
    Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
    Hu C; Chen X; Huang Y; Chen Y
    Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
    Hu C; Chen X; Huang Y; Chen Y
    Sci Rep; 2018 Feb; 8(1):2274. PubMed ID: 29396568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest and apoptosis via caspase activation of dioscoreanone in human non-small-cell lung cancer A549 cells.
    Hansakul P; Aree K; Tanuchit S; Itharat A
    BMC Complement Altern Med; 2014 Oct; 14():413. PubMed ID: 25342427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo.
    Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D
    Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.
    Yaghoubi A; Asgharzadeh F; Movaqar A; Ghazvini K; Hassanian SM; Avan A; Khazaei M; Soleimanpour S
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2851-2865. PubMed ID: 34117917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines.
    Zhao J; Hao X; Liu D; Huang Y; Chen Y
    PLoS One; 2015; 10(9):e0139578. PubMed ID: 26422386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor effects of the BRBP1 compound peptide BRBP1-TAT-KLA on human brain metastatic breast cancer.
    Fu B; Long W; Zhang Y; Zhang A; Miao F; Shen Y; Pan N; Gan G; Nie F; He Y; Zhang J; Teng G
    Sci Rep; 2015 Jan; 5():8029. PubMed ID: 25619721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesiferol c induces apoptosis via regulation of L11 and c-Myc with combinational potential with anticancer drugs in non-small-cell lung cancers.
    Jung JH; Kim MJ; Lee H; Lee J; Kim J; Lee HJ; Shin EA; Kim YH; Kim B; Shim BS; Kim SH
    Sci Rep; 2016 May; 6():26844. PubMed ID: 27231235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effect of the water extract of a commercial Spirulina (Arthrospira platensis) product on the human lung cancer A549 cell line.
    Czerwonka A; Kaławaj K; Sławińska-Brych A; Lemieszek MK; Bartnik M; Wojtanowski KK; Zdzisińska B; Rzeski W
    Biomed Pharmacother; 2018 Oct; 106():292-302. PubMed ID: 29966973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.
    Sławińska-Brych A; Zdzisińska B; Dmoszyńska-Graniczka M; Jeleniewicz W; Kurzepa J; Gagoś M; Stepulak A
    Toxicology; 2016 May; 357-358():65-73. PubMed ID: 27317025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalochromin induces G0/G1 cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by inflicting mitochondrial disruption.
    Hsiao CJ; Hsiao G; Chen WL; Wang SW; Chiang CP; Liu LY; Guh JH; Lee TH; Chung CL
    J Nat Prod; 2014 Apr; 77(4):758-65. PubMed ID: 24588135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.
    Frese S; Brunner T; Gugger M; Uduehi A; Schmid RA
    J Thorac Cardiovasc Surg; 2002 Jan; 123(1):168-74. PubMed ID: 11782771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.
    Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH
    J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
    Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lin MX; Lin SH; Lin CC; Yang CC; Yuan SY
    Anticancer Res; 2018 Jun; 38(6):3435-3445. PubMed ID: 29848694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.